Safety study of DWP212525 in healthy adults
Part of Immune system & allergy clinical trials.
This trial studies a new drug (DWP212525) in healthy volunteers to see how safe it is and how the body processes it. If you are a generally healthy adult, you could help researchers learn about the drug's effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 55 years old.
- You weigh between 110 and 198 pounds (50–90 kg) and have a BMI between 18 and 30.
- You have no current or past liver disease, cancer, or blood disorders.
- You have not had tuberculosis or tested positive for it.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational drug to see if it is safe and how the body processes it. It is for healthy adults who are willing to participate in a closely monitored clinical trial.
This study tests a new experimental injection in healthy volunteers to see if it's safe and how well the body absorbs it. Researchers will compare it with other similar treatments to understand how it works.
This trial is testing a new medication called DW4421. It's an early-stage study to see how safe the drug is and how it affects healthy people. Participants will receive the drug multiple times to help doctors understand dosing.
This trial tests two experimental drugs (DW4421-T1 and DW4421S-T1) to see if they are safe and how the body processes them. It is an early-phase study in healthy adults, so participants will not have the target disease but will help check safety.
This trial tests two forms of a new drug, DW4421 and DW4421S, to see how safe they are and how the body processes them. It is for healthy volunteers aged 19 to 50.
This study tests a new investigational drug called ID110521156 in healthy adults. The goal is to see if the drug is safe and how the body processes it. It may be for people who are overweight or obese.
Hear when a new Autoimmune Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.